The past two months have been eventful for my number one stock pick ADMA Biologics (Nasdaq: ADMA). Moreover, on Friday May 24th, 2019 I added a new stock to the MS portfolio- Regenxbio (Nasdaq: RGNX). In this article, I want to take . . .
*90% Of Traders
At MS Money Moves we leverage our teams expertise in science, business, and technical analysis identifying gainful biotech trades.
Try it for free, Let's get it!
MS Money Moves would like to offer you the opportunity to express your unique perspective regarding publicly traded companies via our website.
All we ask is you write clearly, concisely, and have original ideas. Interested? Contact us now.